|
Building on a Proud History of Discovery
Orthopaedic Hospital has been a leader in orthopaedic science for nearly 100 years and has one of the largest pediatric orthopaedic programs in the world. Our research has driven many discoveries for the prevention and treatment of musculoskeletal conditions and we've treated more than two million people with crippling disorders. We've also built a proud reputation for helping children, regardless of their family's ability to pay. And now, a new era of scientific discovery has begun with the creation of the Orthopaedic Hospital Research Center at UCLA.
A Powerful Collaboration, An Unprecedented Opportunity
For the first time, two of the world's leading medical institutions, Orthopaedic Hospital and UCLA, have aligned to create the nation's most powerful scientific force for preventing and healing diseases of the musculoskeletal system. Working side by side in the scientifically advanced Orthopaedic Hospital Research Center, brilliant minds from all aspects of orthopaedic research are collaborating to shorten the distance between beaker and bedside. This is speeding the path to breakthrough treatments and paving the way for previously unimaginable cures.
|
"As a clinician-scientist, I have dedicated my career to advancing our understanding of the molecular basis, as well as the diagnosis, treatment and prevention of diseases that put the human skeleton at increased risk."
|
John S. Adams, M.D.
Vice Chair for Research, UCLA and
Orthopaedic Hospital Department
of Orthopaedic Surgery
|
New Cures, New Hope for All
We look forward to a day when the genes that cause scoliosis will be indentified and re-engineered so that no child will experience severe curvature of the spine, when children will no longer be born with femur bones that don't develop properly and commit them to a life of partial stature and pain, and when we'll be able to prevent osteoporosis and fractures in later life by knowing how to prevent its crucial beginnings in adolescence. Thanks to emerging advances in molecular and human genetics, nanotechnology, bioengineering and non-embryonic stem cell biology, breakthroughs are on the horizon. They come not a moment too soon. Millions of baby boomers are quickly approaching the osteoarthritis stage of their lives. Within the next 10 years, these and other musculoskeletal conditions could approach epidemic proportions. With the establishment of the Orthopaedic Hospital Research Center, scientists now have the ideal setting and resources to find new treatments and cures for traumatic and non-traumatic injury to the musculoskeletal system.
This will include, but not be confined to, research on:
- Arthritis and Arthropathies
- Developmental Diseases such as Muscular Dystrophy, Cerebral Palsy and Dwarfism
- Hip, Knee, Shoulder, Ankle and Spine Replacement
- Musculoskeletal Cancer
- Musculoskeletal Tissue Repair and Regeneration
- Osteoporosis
- Pediatric and Adult Fracture Syndromes
|
"Researchers have the opportunity to work closely with clinicians to ensure that we are focusing on work that will have a direct impact on patient care, including improved treatments, the prevention of some severe orthopaedic conditions and cures for others."
|
Paul Benya, Ph.D.
Director of Cartilage Cell Biology,
Orthopaedic Hospital Research Center
|
Governance
Accountability is a hallmark of the research conducted at this Center. The Executive Committee for Research and the Orthopaedic Hospital Board of Directors provide oversight, while John Adams, M.D., Vice Chair for Research, is responsible for research operations and administration. Dr. Adams regularly reports to the Executive Committee which includes Orthopaedic Hospital's CEO, the Chair of the UCLA/OH Department of Orthopaedic Surgery and three Orthopaedic Hospital board members.
Continue: Giving
|
|
|
Video: Research Center coverage
Requires Flash Plugin
Exterior of Research Center
Inside the Research Center
"By uniting experts engaged in a wide spectrum of studies, Orthopaedic Hospital and UCLA researchers are fostering biomedical discoveries that will result in a dramatic shift in medical treatments for a variety of musculoskeletal conditions, including arthritis, osteoporosis, cerebral palsy, birth defects and fractures."
James V. Luck Jr., M.D.
President, Chief Executive Officer
and Medical Director,
Orthopaedic Hospital
|
|
|
